Effective at the market close on Friday March 12, VIE will be removed from the LifeSci Biotechnology Products Index and its values will be redistributed to the remaining index components based on their weights.
On February 1, 2021, Viela Bio agreed to be acquired by Horizon Therapeutics plc for $53.00 per share in cash.
